WALTHAM, Mass.--(BUSINESS WIRE)--Paragonix Technologies, a pioneer in organ transplant technologies and organ procurement services, announced today the completion of the world’s first donor kidney ...

Get insights from Vertex Pharmaceuticals' Q3 2025 earnings call—revenue growth, pipeline milestones, and outlook for ALYFTREK, CASGEVY, and JOURNAVX.

After claiming an FDA clearance last October, Paragonix Technologies reported that its donor kidney transportation system has completed its first commercial flight in a quick hop from Arizona to a ...

Q3 2025 Management View Cedric Francois, CEO, highlighted the recent FDA approval of EMPAVELI for patients 12 years and older with C3 glomerulopathy and primary IC-MPGN, noting this expands EMPAVELI’s ...

Hospital-acquired acute kidney injury (HA-AKI) is a common complication in hospitalized patients that can lead to chronic kidney disease and is associated with longer hospital stays, higher health ...

DALLAS, March 27, 2025 /PRNewswire/ — Medi-Ops, a technology-enabled medical logistics organization, and Southwest Transplant Alliance (STA), an organization committed to the advancement of transplant ...

Discover key Q3 2025 earnings insights for Travere Therapeutics, including FILSPARI sales growth, FDA milestones, and outlook for rare kidney ...